SMARCA4 and ovarian cancer: Therefore, unlike SMARCA4-mutant NSCLC cells with intact SMARCA238, the OXPHOS dependency in SMARCA4/2-deficient ovarian cancer cells is not due to increased OXPHOS activity, but rather attributed to repressed glycolysis.